Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?

被引：0
|
作者：
Hamedi, Z. [1 ]
Kamboj, S. [2 ]
Kumar, S. [1 ]
Jiwani, R. A. [1 ]
Sharma, N. [2 ]
机构：
[1] East Carolina Univ, Vidant Med Ctr, Internal Med, Greenville, NC 27858 USA
[2] East Carolina Univ, Vidant Med Ctr, Hematol & Oncol, Greenville, NC 27858 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [23] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [25] THE EFFECT OF TWO BRM PROMOTER POLYMORPHISMS ON THE RISK OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC) IN SMOKERS
    Cuffe, Sinead
    Qiu, Xin
    Patel, Devalben
    Azad, Abul K.
    Cheng, Dangxiao
    Chen, Zhuo
    Boyd, Kevin
    Leighl, Natasha
    Xu, Wei
    Shepherd, Frances A.
    Tsao, Ming S.
    Reisman, David N.
    Liu, Geoffrey
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S285 - S286
  • [26] Current knowledge of small cell lung cancer transformation from non-small cell lung cancer
    Giaccone, Giuseppe
    He, Yongfeng
    SEMINARS IN CANCER BIOLOGY, 2023, 94 : 1 - 10
  • [27] The role of ifosfamide in non-small cell lung cancer (NSCLC) treatment
    Manegold, K
    EXPERIMENTAL ONCOLOGY, 1996, 18 (01): : 69 - 72
  • [28] New perspectives in the treatment of non-small cell lung cancer (NSCLC)
    Brockmoeller, Juergen
    Junker, Klaus
    Multhoff, Gabriele
    ONKOLOGIE, 2006, 29 : 25 - 28
  • [29] IMPROVING TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Reck, M.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4038
  • [30] Carboplatin/paclitaxelAcquired drug resistance and transformation of non-small cell lung cancer to small cell lung cancer: case report
    Reactions Weekly, 2020, 1804 (1) : 88 - 88
12345